Loading...

SNOA SONOMA PHARMACEUTICALS INC Capital Structure Changes 8-K Filing

SNM

SN

SONOMA PHARMACEUTICALS INC

(SNOA)

2025 8-K

Summary

Summary

Management Changes

Investor Presentation Update

Stock Sale Agreement

Annual Meeting Results

Investor Presentation

Investor Presentation

Supply Agreement Update

Supply Agreement

Agreement Termination

Distribution Agreement

Equity Distribution

Stock Split Approval

Distribution Agreement

Equity Distribution Agreement

Investor Presentation

Investor Conferences

Delisting Notice

Equity Distribution Agreement

Regulation FD Disclosure

Agreement with NovaBay Phar...

Stock Options Grant

Equity Distribution Agreement

Amendment to Form 8-K

Investor Presentation

Investor Presentation

Management Changes

Amendment to At-The-Market ...

Distribution Agreement

Investor Presentation

External Links:

On September 26, 2025, Sonoma Pharmaceuticals, Inc. announced it entered an agreement with Ladenburg Thalmann to sell up to $2,070,463 of its common stock on the Nasdaq market. The company will pay a 3% commission on sales under this agreement.

AI Assistant

SONOMA PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.